APOC2 and non-small cell lung carcinoma: In non-small cell lung cancer, APOC2 K70 lactylation is substantially upregulated in patients resistant to immunotherapy and is negatively linked to overall survival in both non-small cell lung cancer and gastric cancer (Chen J. et al., 2024).